The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
As described in the morning session, regulatory expectations continue to evolve given the complexities associated with new products and innovation. This session will provide an opportunity to hear more about this topic in the context of an innovative vaccine facility and related sterile manufacturing requirements.
Moderator(s):
Stephen
Mahoney,
Executive Director, Global Quality & Compliance,
Genentech, A Member of the Roche Group
Speaker(s):
Maria
Hoffman,
Executive Director, Supply Chain Management,
Merck & Co., Inc.
Patricia
Hughes,
PhD,
Branch Chief, Division of Microbiology Assessment,
CDER/FDA
Credits
Credits: None available.
You must be logged in and own this session in order to
post comments.